Showing results (261-270 of 367) with videos related to
Sort By:
Pageof 37
Cancer Immunology Research|June 9, 2022
In Vivo Syngeneic Tumor Models with Acquired Resistance to Anti-PD-1/PD-L1 TherapiesMorgane Denis, Chloé Grasselly, Pierre-Antoine Choffour, et al.Electrophoresis|October 19, 2004
Electrophoretic separation of amyloid beta peptides in plasmaPiotr Lewczuk, Hermann Esselmann, Mirko Bibl, et al.The Journal of Biological Chemistry|May 21, 2014
A novel glycoengineered bispecific antibody format for targeted inhibition of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor type I (IGF-1R) demonstrating unique molecular propertiesJuergen M Schanzer, Katharina Wartha, Rebecca Croasdale, et al.Rheumatology (Oxford, England)|August 1, 2020
Targeted photodynamic therapy selectively kills activated fibroblasts in experimental arthritisDaphne N Dorst, Mark Rijpkema, Marti Boss, et al.Oncoimmunology|September 2, 2025
Chronic antigen stimulation in melanoma induces T cell exhaustion and limits efficacy of T cell bispecific therapiesIdil Hutter-Karakoc, Eleni Maria Varypataki, Aparna Neelakandhan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2016
In Vivo Fluorescence Imaging of the Activity of CEA TCB, a Novel T-Cell Bispecific Antibody, Reveals Highly Specific Tumor Targeting and Fast Induction of T-Cell-Mediated Tumor KillingSteffi Lehmann, Ramanil Perera, Hans-Peter Grimm, et al.Oncotarget|January 27, 2018
A comparative global phosphoproteomics analysis of obinutuzumab (GA101) versus rituximab (RTX) against RTX sensitive and resistant Burkitt lymphoma (BL) demonstrates differential phosphorylation of signaling pathway proteins after treatmentAradhana Awasthi, Delphine C M Rolland, Janet Ayello, et al.Journal for Immunotherapy of Cancer|January 23, 2025
PD-1 cis-targeted IL-2v in combination with radiotherapy inhibits lung cancer growth and remodels the immune microenvironmentCéline Godfroid, Jackeline Romero, Sara Labiano, et al.Cancer Immunology Research|September 19, 2019
Trabectedin Reveals a Strategy of Immunomodulation in Chronic Lymphocytic LeukemiaPriyanka Banerjee, Ronghua Zhang, Cristina Ivan, et al.Mabs|April 28, 2026
Engineering of acidic pH-responsive anti-CD3 binding antibodiesGrégory La Sala, Katharina B Kroell, Mudita Pincha, et al.Pageof 37